{"id":971980,"date":"2026-06-15T08:03:40","date_gmt":"2026-06-15T12:03:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/"},"modified":"2026-06-15T08:03:40","modified_gmt":"2026-06-15T12:03:40","slug":"coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/","title":{"rendered":"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>Virtual Live Webinar Set for Wednesday, June 24 at 4 p.m. ET \/ 1 p.m. PT<\/i><\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><i>Will be moderated by Solomon Wilcots and feature discussion and insights from CNS experts, Stanley H. Appel, M.D., Fred Grossman D.O. and leading sports agent and concussion awareness advocate Leigh Steinberg<\/i><\/li>\n<\/ul>\n<p>HOUSTON&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.coyatherapeutics.com%2F&amp;esheet=54553083&amp;newsitemid=20260615899187&amp;lan=en-US&amp;anchor=Coya+Therapeutics%2C+Inc.&amp;index=1&amp;md5=b5616e072b773d68759ae66ab793e21a\">Coya Therapeutics, Inc.<\/a> (NASDAQ: COYA) (\u201cCoya\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced it will host a live webinar on June 24, 2026 at 4 p.m. ET \/ 1 p.m. PT.<\/p>\n<p>\nTitled <b>\u2018Beyond the Hit: How Repetitive Head Trauma, Inflammation, and Neurodegenerative Disease Intersect\u2019<\/b>, the webinar will explore the relationship between repetitive head trauma, chronic inflammation, and neurodegenerative diseases, including chronic traumatic encephalopathy (CTE) and Amyotrophic lateral sclerosis (ALS), featuring insights from leaders in sports advocacy, clinical neurology, and therapeutic research.<\/p>\n<p><b>Solomon Wilcots<\/b>, NFL broadcaster and former player for the Cincinnati Bengals, will serve as the moderator for the webinar. He will be joined by the following participants:<\/p>\n<ul class=\"bwlistdisc\">\n<li><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.houstonmethodist.org%2Fdoctor%2Fstanley-appel%2F&amp;esheet=54553083&amp;newsitemid=20260615899187&amp;lan=en-US&amp;anchor=Stanley+H.+Appel%2C+M.D&amp;index=2&amp;md5=a74e64947aa48a9bcdf128e8771abeb4\"><b>Stanley H. Appel, M.D<\/b><\/a>. \u2013 Edwards Distinguished Endowed Chair in ALS Research Professor, Stanley H. Appel Department of Neurology Houston Methodist Research Institute\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Ffredgrossman%2F&amp;esheet=54553083&amp;newsitemid=20260615899187&amp;lan=en-US&amp;anchor=Fred+Grossman+D.O.&amp;index=3&amp;md5=5cfa04150a90a0dea368fe4b7cc7269e\"><b>Fred Grossman D.O.<\/b><\/a> \u2013 President and Chief Medical Officer of Coya Therapeutics\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Flesteinberg%2F&amp;esheet=54553083&amp;newsitemid=20260615899187&amp;lan=en-US&amp;anchor=Leigh+Steinberg&amp;index=4&amp;md5=c048351355b295f78ba299f32dbbb99e\"><b>Leigh Steinberg<\/b><\/a> \u2013 Premier Sports Agent, Chairman, Steinberg Sports &amp; Entertainment\n<\/li>\n<\/ul>\n<p><span class=\"bwuline\">Webinar Information<\/span><\/p>\n<p>\nPre-registration is now open <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Frussopr.zoom.us%2Fwebinar%2Fregister%2FWN_EtIIz8PORk2pLEaM8pgNQQ&amp;esheet=54553083&amp;newsitemid=20260615899187&amp;lan=en-US&amp;anchor=HERE&amp;index=5&amp;md5=931cf972cf4ec3194e6349d6e92ff4ff\">HERE<\/a><\/p>\n<p><b>Date<\/b>: June 24, 2026<\/p>\n<p><b>Time<\/b>: 4 pm ET \/ 1 pm PT<\/p>\n<p>\nAttendees may ask questions via written Q&amp;A. A recording of the event will be posted to the Coya Therapeutics <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.coyatherapeutics.com%2Fevents-and-presentations%2Fdefault.aspx&amp;esheet=54553083&amp;newsitemid=20260615899187&amp;lan=en-US&amp;anchor=website&amp;index=6&amp;md5=6828a38d48dbb695487002eed5342038\">website<\/a>.<\/p>\n<p><b>About Coya Therapeutics, Inc.<\/b><\/p>\n<p>\nHeadquartered in Houston, TX, Coya Therapeutics, Inc. (Nasdaq: COYA) is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells (\u201cTregs\u201d) to target systemic inflammation and neuroinflammation. Dysfunctional Tregs underlie numerous conditions, including neurodegenerative, metabolic, and autoimmune diseases. This cellular dysfunction may lead to sustained inflammation and oxidative stress resulting in lack of homeostasis of the immune system.<\/p>\n<p>\nCoya\u2019s investigational product candidate pipeline leverages multiple therapeutic modalities aimed at restoring the anti-inflammatory and immunomodulatory functions of Tregs. Coya\u2019s therapeutic platforms include Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.<\/p>\n<p>\nFor more information about Coya, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.coyatherapeutics.com&amp;esheet=54553083&amp;newsitemid=20260615899187&amp;lan=en-US&amp;anchor=www.coyatherapeutics.com&amp;index=7&amp;md5=d2756f651f17f0e645bc6ab341b15360\">www.coyatherapeutics.com<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260615899187\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260615899187\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact<br \/>\n<\/b><br \/>David Snyder, CFO<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:david@coyatherapeutics.com\">david@coyatherapeutics.com<\/a><\/p>\n<p><b>Media Contacts<br \/>\n<\/b><br \/>Russo Partners<br \/>\n<\/p>\n<p>\nDavid Schull<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:David.Schull@russopartnersllc.com\">David.Schull@russopartnersllc.com<br \/>\n<\/a><br \/>858-717-2310<br \/>\n<\/p>\n<p>\nRachelle Babb<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:rachelle.babb@russopartnersllc.com\">rachelle.babb@russopartnersllc.com<br \/>\n<\/a><br \/>929-325-7559<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Texas<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Research General Sports Sports Neurology Clinical Trials Football Biotechnology Health Science<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260615899187\/en\/2830636\/3\/Coya_Therapeutics_Transparent_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease Virtual Live Webinar Set for Wednesday, June 24 at 4 p.m. ET \/ 1 p.m. PT Will be moderated by Solomon Wilcots and feature discussion and insights from CNS experts, Stanley H. Appel, M.D., Fred Grossman D.O. and leading sports agent and concussion awareness advocate Leigh Steinberg HOUSTON&#8211;(BUSINESS WIRE)&#8211;Coya Therapeutics, Inc. (NASDAQ: COYA) (\u201cCoya\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced it will host a live webinar on June 24, 2026 at 4 p.m. ET \/ 1 p.m. PT. Titled \u2018Beyond the Hit: How Repetitive Head Trauma, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-971980","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease Virtual Live Webinar Set for Wednesday, June 24 at 4 p.m. ET \/ 1 p.m. PT Will be moderated by Solomon Wilcots and feature discussion and insights from CNS experts, Stanley H. Appel, M.D., Fred Grossman D.O. and leading sports agent and concussion awareness advocate Leigh Steinberg HOUSTON&#8211;(BUSINESS WIRE)&#8211;Coya Therapeutics, Inc. (NASDAQ: COYA) (\u201cCoya\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced it will host a live webinar on June 24, 2026 at 4 p.m. ET \/ 1 p.m. PT. Titled \u2018Beyond the Hit: How Repetitive Head Trauma, &hellip; Continue reading &quot;Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-15T12:03:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease\",\"datePublished\":\"2026-06-15T12:03:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/\"},\"wordCount\":464,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/\",\"name\":\"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-06-15T12:03:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/","og_locale":"en_US","og_type":"article","og_title":"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease - Market Newsdesk","og_description":"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease Virtual Live Webinar Set for Wednesday, June 24 at 4 p.m. ET \/ 1 p.m. PT Will be moderated by Solomon Wilcots and feature discussion and insights from CNS experts, Stanley H. Appel, M.D., Fred Grossman D.O. and leading sports agent and concussion awareness advocate Leigh Steinberg HOUSTON&#8211;(BUSINESS WIRE)&#8211;Coya Therapeutics, Inc. (NASDAQ: COYA) (\u201cCoya\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced it will host a live webinar on June 24, 2026 at 4 p.m. ET \/ 1 p.m. PT. Titled \u2018Beyond the Hit: How Repetitive Head Trauma, &hellip; Continue reading \"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-15T12:03:40+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease","datePublished":"2026-06-15T12:03:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/"},"wordCount":464,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/","name":"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-06-15T12:03:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260615899187r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/coya-therapeutics-to-host-virtual-webinar-on-the-intersection-of-repetitive-head-trauma-brain-inflammation-and-neurodegenerative-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/971980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=971980"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/971980\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=971980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=971980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=971980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}